Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$89.87
6.607.93%
À la fermeture: Nov 21, 4:00 PM EST
$90.36
0.490.55%
Après les heures de négociation: 7:49 PM EST
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Inspire Medical Systems Inc a un objectif de cours consensuel de $171.63 basé sur les évaluations de 20 analystes. Le plus élevé est $340, publié par Piper Sandler le juin 8, 2023. Le plus bas est $82, publié par JP Morgan le novembre 4, 2025. Les 3 évaluations d’analystes les plus récentes ont été publiées par Piper Sandler, RBC Capital et Truist Securities le novembre 4, 2025, respectivement. Avec un objectif de cours moyen de $114.67 entre Piper Sandler, RBC Capital et Truist Securities, il existe une variation implicite de 26.90% upside pour Inspire Medical Systems Inc selon ces dernières évaluations d’analystes.
Sociétés d'analyse émettant des recommandations1
Piper Sandler
RBC Capital
Truist Securities
JP Morgan
Wells Fargo
1calculé à partir des notes des analystes
Notes d'analystes pour Inspire Medical Systems
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/04/2025 | 49.4% | Piper Sandler | $150 → $135 | Reiterates | Overweight → Overweight | |||
11/04/2025 | 38.34% | RBC Capital | $150 → $125 | Maintains | Outperform | |||
11/04/2025 | -7.04% | Truist Securities | $90 → $84 | Reiterates | Hold → Hold | |||
11/04/2025 | -9.25% | JP Morgan | $110 → $82 | Maintains | Neutral | |||
11/04/2025 | -0.4% | Wells Fargo | $101 → $90 | Upgrade | Equal-Weight → Overweight | |||
10/24/2025 | -5.93% | Jefferies | $160 → $85 | Downgrade | Buy → Hold | |||
10/15/2025 | -0.4% | Truist Securities | $125 → $90 | Maintains | Hold | |||
10/07/2025 | 38.34% | Evercore ISI Group | $150 → $125 | Maintains | Outperform | |||
09/22/2025 | -1.51% | UBS | $230 → $89 | Downgrade | Buy → Neutral | |||
09/02/2025 | 66% | Evercore ISI Group | → $150 | Initiates | → Outperform | |||
08/15/2025 | 7.35% | Leerink Partners | $116 → $97 | Maintains | Market Perform | |||
08/05/2025 | 28.38% | Leerink Partners | $149 → $116 | Maintains | Market Perform | |||
08/05/2025 | 38.34% | Truist Securities | $190 → $125 | Downgrade | Buy → Hold | |||
08/05/2025 | 66% | Lake Street | $270 → $150 | Maintains | Buy | |||
08/05/2025 | 11.78% | Wells Fargo | $174 → $101 | Maintains | Equal-Weight | |||
08/05/2025 | 154.54% | UBS | $270 → $230 | Maintains | Buy | |||
08/05/2025 | 99.2% | RBC Capital | $215 → $180 | Maintains | Outperform | |||
08/05/2025 | 54.94% | Stifel | $175 → $140 | Maintains | Hold | |||
08/05/2025 | 66% | Piper Sandler | $233 → $150 | Maintains | Overweight | |||
08/05/2025 | 21.74% | JP Morgan | $195 → $110 | Downgrade | Overweight → Neutral | |||
08/05/2025 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
07/22/2025 | 118.02% | Keybanc | $216 → $197 | Maintains | Overweight | |||
07/15/2025 | 101.42% | Morgan Stanley | $200 → $182 | Maintains | Overweight | |||
07/14/2025 | 64.9% | Leerink Partners | $176 → $149 | Maintains | Market Perform | |||
05/06/2025 | 121.34% | Morgan Stanley | $220 → $200 | Maintains | Overweight | |||
05/06/2025 | 115.8% | JP Morgan | $235 → $195 | Maintains | Overweight | |||
05/06/2025 | 92.56% | Wells Fargo | $195 → $174 | Maintains | Equal-Weight | |||
05/06/2025 | 161.18% | Baird | $230 → $236 | Maintains | Outperform | |||
05/05/2025 | 94.78% | Leerink Partners | $194 → $176 | Maintains | Market Perform | |||
04/21/2025 | 93.67% | Stifel | $190 → $175 | Maintains | Hold | |||
04/21/2025 | 139.04% | Keybanc | $234 → $216 | Maintains | Overweight | |||
04/15/2025 | 137.94% | RBC Capital | $260 → $215 | Maintains | Outperform | |||
02/11/2025 | 114.7% | Leerink Partners | $193 → $194 | Maintains | Market Perform | |||
02/11/2025 | 160.07% | Truist Securities | $250 → $235 | Maintains | Buy | |||
02/11/2025 | 187.74% | RBC Capital | $260 → $260 | Reiterates | Outperform → Outperform | |||
02/11/2025 | 174.46% | Baird | $252 → $248 | Maintains | Outperform | |||
02/11/2025 | 115.8% | Wells Fargo | $198 → $195 | Maintains | Equal-Weight | |||
02/11/2025 | 143.47% | Morgan Stanley | $230 → $220 | Maintains | Overweight | |||
02/10/2025 | 157.86% | Piper Sandler | $260 → $233 | Maintains | Overweight | |||
01/24/2025 | 158.96% | Keybanc | $236 → $234 | Reiterates | Overweight → Overweight | |||
01/21/2025 | 110.27% | Stifel | $200 → $190 | Maintains | Hold | |||
11/20/2024 | 182.2% | B of A Securities | $220 → $255 | Upgrade | Neutral → Buy | |||
11/05/2024 | 176.67% | Truist Securities | $240 → $250 | Maintains | Buy | |||
11/05/2024 | 154.54% | Morgan Stanley | $210 → $230 | Maintains | Overweight | |||
11/05/2024 | 187.74% | RBC Capital | $260 → $260 | Reiterates | Outperform → Outperform | |||
11/05/2024 | 187.74% | Piper Sandler | $255 → $260 | Reiterates | Overweight → Overweight | |||
11/05/2024 | 121.34% | Stifel | $170 → $200 | Reiterates | Hold → Hold | |||
11/05/2024 | 119.12% | Wells Fargo | $187 → $198 | Maintains | Equal-Weight | |||
11/05/2024 | 178.88% | Baird | $240 → $252 | Maintains | Outperform | |||
09/30/2024 | 165.6% | Truist Securities | $217 → $240 | Reiterates | Buy → Buy | |||
09/10/2024 | 118.02% | Leerink Partners | $167 → $197 | Maintains | Market Perform | |||
08/07/2024 | 161.18% | Keybanc | $278 → $236 | Maintains | Overweight | |||
08/07/2024 | 187.74% | RBC Capital | $260 → $260 | Reiterates | Outperform → Outperform | |||
08/07/2024 | 121.34% | Baird | $220 → $200 | Maintains | Outperform | |||
07/16/2024 | 140.15% | Truist Securities | $280 → $217 | Maintains | Buy | |||
07/15/2024 | 132.4% | Morgan Stanley | $250 → $210 | Maintains | Overweight | |||
06/24/2024 | 88.14% | Stifel | $210 → $170 | Maintains | Hold | |||
06/03/2024 | 104.74% | B of A Securities | $225 → $185 | Maintains | Neutral | |||
05/08/2024 | 182.2% | Piper Sandler | $250 → $255 | Maintains | Overweight | |||
04/19/2024 | 215.41% | RBC Capital | → $285 | Initiates | → Outperform | |||
03/27/2024 | 176.67% | Mizuho | $250 → $250 | Maintains | Buy | |||
03/20/2024 | 209.87% | Truist Securities | → $280 | Reiterates | Buy → Buy | |||
03/19/2024 | 176.67% | Morgan Stanley | → $250 | Initiates | → Overweight | |||
02/07/2024 | 209.87% | Truist Securities | $265 → $280 | Maintains | Buy | |||
02/07/2024 | 176.67% | Mizuho | $225 → $250 | Maintains | Buy | |||
02/06/2024 | 207.66% | Keybanc | → $278 | Initiates | → Overweight | |||
01/19/2024 | 171.14% | Jefferies | — | → $245 | Initiates | → Buy | ||
01/02/2024 | 132.4% | Stifel | → $210 | Downgrade | Buy → Hold | |||
12/22/2023 | 187.74% | Truist Securities | $240 → $260 | Maintains | Buy | |||
12/13/2023 | 106.95% | Wells Fargo | → $187 | Downgrade | Overweight → Equal-Weight | |||
11/08/2023 | 132.4% | Stifel | $250 → $210 | Maintains | Buy | |||
11/08/2023 | 137.94% | Mizuho | $300 → $215 | Maintains | Buy | |||
11/08/2023 | 165.6% | Truist Securities | $260 → $240 | Maintains | Buy | |||
11/08/2023 | 171.14% | Wells Fargo | $330 → $245 | Maintains | Overweight | |||
11/07/2023 | 176.67% | Stifel | $350 → $250 | Maintains | Buy | |||
10/17/2023 | 100.31% | JP Morgan | $340 → $181 | Maintains | Overweight | |||
10/16/2023 | 75.96% | Leerink Partners | → $159 | Initiates | → Market Perform | |||
10/02/2023 | 276.27% | Truist Securities | → $340 | Reiterates | Buy → Buy | |||
09/06/2023 | 256.35% | UBS | $405 → $322 | Maintains | Buy | |||
08/24/2023 | 276.27% | Truist Securities | $363 → $340 | Maintains | Buy | |||
08/02/2023 | 276.27% | JP Morgan | $300 → $340 | Maintains | Overweight | |||
08/02/2023 | 287.34% | Lake Street | $305 → $350 | Maintains | Buy | |||
08/02/2023 | 301.73% | Truist Securities | $380 → $363 | Maintains | Buy | |||
08/02/2023 | 265.21% | Wells Fargo | $315 → $330 | Maintains | Overweight | |||
07/19/2023 | 320.54% | Truist Securities | $360 → $380 | Maintains | Buy | |||
07/19/2023 | 310.58% | Baird | → $371 | Initiates | → Outperform | |||
07/13/2023 | 287.34% | Stifel | $300 → $350 | Maintains | Buy | |||
07/05/2023 | 292.87% | B of A Securities | $310 → $355 | Maintains | Buy | |||
06/12/2023 | 232.01% | Mizuho | → $300 | Reiterates | Buy → Buy | |||
06/08/2023 | 276.27% | Piper Sandler | $315 → $340 | Maintains | Overweight | |||
06/08/2023 | 270.74% | Keybanc | $321 → $335 | Maintains | Overweight | |||
05/18/2023 | 298.41% | Piper Sandler | $335 → $360 | Maintains | Overweight | |||
05/03/2023 | 236.43% | UBS | $300 → $304 | Maintains | Buy | |||
05/03/2023 | 248.61% | Piper Sandler | $305 → $315 | Maintains | Overweight | |||
05/03/2023 | 255.25% | Keybanc | $303 → $321 | Maintains | Overweight | |||
04/14/2023 | 232.01% | Mizuho | → $300 | Initiates | → Buy | |||
04/13/2023 | 232.01% | Mizuho | → $300 | Initiates | → Buy | |||
04/11/2023 | 232.01% | Stifel | $290 → $300 | Maintains | Buy | |||
03/29/2023 | 232.01% | UBS | → $300 | Initiates | → Buy | |||
02/08/2023 | 265.21% | Truist Securities | $310 → $330 | Maintains | Buy |
FAQ
Quel est le cours indicatif de l'action Inspire Medical Systems (INSP) ?
Le dernier objectif de prix pour Inspire Medical Systems (NYSE:INSP) a été rapporté par Piper Sandler le novembre 4, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $135.00 s'attendant à ce que INSP se rise dans les 12 prochains mois (un possible changement de 49.40% upside). 41 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Inspire Medical Systems (INSP) ?
La dernière note d'analyste pour Inspire Medical Systems (NYSE:INSP) a été fournie par Piper Sandler, et Inspire Medical Systems réitéré leur note overweight.
Quand a eu lieu la dernière mise à niveau pour Inspire Medical Systems (INSP) ?
La dernière amélioration pour Inspire Medical Systems Inc a eu lieu le novembre 4, 2025 lorsque Wells Fargo a augmenté leur objectif de prix à $90. Wells Fargo avait précédemment an equal-weight pour Inspire Medical Systems Inc.
Quand a eu lieu la dernière dégradation pour Inspire Medical Systems (INSP) ?
La dernière réduction pour Inspire Medical Systems Inc a eu lieu le octobre 24, 2025 lorsque Jefferies a changé leur objectif de prix de $160 à $85 pour Inspire Medical Systems Inc.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Inspire Medical Systems (INSP) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Inspire Medical Systems, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Inspire Medical Systems a été déposée le novembre 4, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 4, 2026.
La note d'analyste pour Inspire Medical Systems (INSP) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Inspire Medical Systems (INSP) était un réitéré avec un objectif de prix de $150.00 à $135.00. Le prix actuel de Inspire Medical Systems (INSP) est de $90.36, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.